Your session is about to expire
Rosuvastatin vs Simvastatin
Introduction
For individuals with high cholesterol or other types of lipid disorders, certain drugs that inhibit the production of cholesterol in the liver can help manage these conditions and prevent cardiovascular diseases. Rosuvastatin and Simvastatin are two such medications commonly prescribed to lower bad cholesterol levels. Both belong to a group of drugs known as statins, which work by blocking an enzyme in your liver that your body uses to make cholesterol.
Rosuvastatin is more potent than simvastatin; it reduces LDL (low-density lipoprotein) or "bad" cholesterol significantly more at all doses when compared to simvastatin. On the other hand, Simvastatin is often recommended due to its long track record and availability as a low-cost generic drug.
Both medications may cause side effects like muscle pain and increase blood sugar levels. However, these side effects vary from person to person depending on their overall health condition.
Rosuvastatin vs Simvastatin Side By Side
| Attribute | Crestor | Zocor |
|---|---|---|
| Brand Name | Crestor | Zocor |
| Contraindications | Should not be taken with drugs that inhibit CYP3A4 such as certain antibiotics (like erythromycin) and antifungal drugs (like itraconazole). | Should not be taken with drugs that inhibit CYP3A4 such as certain antibiotics (like erythromycin) and antifungal drugs (like itraconazole). |
| Cost | Generic rosuvastatin costs between $0.28 and $2.50/day. | Simvastatin ranges from about $.07 to $.80/day. |
| Generic Name | Rosuvastatin | Simvastatin |
| Most Serious Side Effect | Rhabdomyolysis, which could lead to kidney failure. | Rhabdomyolysis, leading to potential kidney failure. |
| Severe Drug Interactions | Drugs that inhibit CYP3A4. | Drugs that inhibit CYP3A4. |
| Typical Dose | 5-40 mg/day, with 10–20mg being effective for most. | 10-20 mg/day, up to a maximum of 40 mg/day. |
What is Rosuvastatin?
Rosuvastatin (the generic name for Crestor) and Simvastatin (generic for Zocor) are both popular choices in the statin class of drugs, which have revolutionized the management of high cholesterol levels and heart disease. Rosuvastatin was approved by the FDA in 2003, whereas Simvastatin gained approval earlier in 1991. Both drugs function by inhibiting an enzyme that plays a key role in cholesterol production, thereby reducing overall cholesterol levels within the body. They are typically prescribed to individuals with elevated low-density lipoprotein (LDL), or "bad" cholesterol, as part of a treatment plan to prevent cardiovascular events such as strokes or heart attacks.
While similar on many fronts, there are some key differences between these two medications. Rosuvastatin is more potent than Simvastatin; thus it can produce greater reductions in LDL cholesterol levels at equivalent doses. Also noteworthy is their difference in specificity: whilst both inhibit our bodies’ ability to make LDL-cholesterol effectively decreasing its level, Rosuvastatin has also shown potential benefits increasing high-density lipoprotein (HDL), or "good" cholesterol levels—something not observed significantly with Simvastatin use.
What conditions is Rosuvastatin approved to treat?
Rosuvastatin is approved for the treatment of various cholesterol-related conditions:
- Primary hyperlipidemia and mixed dyslipidemia, types of high cholesterol
- Hypertriglyceridemia, a condition characterized by high levels of triglycerides
- Homozygous familial hypercholesterolemia, a genetic disorder leading to extremely high cholesterol
- Prevention of cardiovascular disease in individuals who are at risk.
How does Rosuvastatin help with these illnesses?
Rosuvastatin helps to manage high cholesterol by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. By blocking this enzyme, less cholesterol is produced and released into the bloodstream. Cholesterol is a type of fat that can build up on artery walls if levels are too high, forming plaques that restrict blood flow and increase risk for heart disease and stroke. It's believed that individuals with high levels of "bad" LDL cholesterol have an increased risk of these conditions. Therefore, by reducing LDL cholesterol levels, rosuvastatin can help patients manage their condition and reduce their cardiovascular risk.
Simvastatin works similarly to rosuvastatin as it also blocks HMG-CoA reductase thus limiting cholesterol production in the liver. However, they differ mainly when it comes to potency where rosuvastatin is known to be more potent than simvastatin at equivalent doses.
What is Simvastatin?
Simvastatin, marketed under the trade name Zocor among others, is a lipid-lowering medication. It's a type of drug known as an HMG-CoA reductase inhibitor or statin. This means it works in the liver to reduce levels of "bad" cholesterol (low-density lipoprotein or LDL) and raise "good" cholesterol (high-density lipoprotein or HDL). Simvastatin was first approved by the FDA in 1991 and has since become one of the most commonly prescribed medications for high cholesterol. Unlike rosuvastatin, simvastatin also reduces levels of triglycerides which are another unhealthy type of fat in your blood that can increase your risk for heart disease if too high. While both drugs have potential side effects such as muscle pain and damage, liver damage and increased blood sugar levels, you may find that simvastatin's additional effect on triglyceride reduction makes it more suitable than rosuvastatin for managing your overall cardiovascular health.
What conditions is Simvastatin approved to treat?
Simvastatin is a statin medication that has been approved for the treatment of:
- High cholesterol and triglycerides, reducing their levels in the blood
- It is also used to reduce the risk of heart attacks, strokes, and other complications in people with diabetes, coronary heart disease or other risk factors.
How does Simvastatin help with these illnesses?
Simvastatin plays a crucial role in the management of high cholesterol levels, affecting the production and utilization of low-density lipoprotein (LDL), often referred to as 'bad cholesterol'. This is achieved by inhibiting an enzyme known as HMG-CoA reductase, which is involved in the body's synthesis of cholesterol. Through this action, simvastatin reduces LDL levels while also modestly increasing high-density lipoprotein (HDL) or 'good' cholesterol. Simvastatin has been implicated in decreasing cardiovascular incidents such as heart attack and stroke due its cholesterol-lowering properties. As with Rosuvastatin, it may be prescribed when a patient's elevated LDL levels are not adequately managed through lifestyle modifications alone. However, compared to Rosuvastatin, simvastatin might cause slightly more side effects like muscle pain but is still considered to be effective and safe for most people.
How effective are both Rosuvastatin and Simvastatin?
Both rosuvastatin (Crestor) and simvastatin (Zocor) have established histories of success in treating patients with high cholesterol, and they were initially approved by the FDA only a few years apart. Since they act on different stages of the cholesterol synthesis pathway, they may be prescribed under different circumstances. The effectiveness of rosuvastatin and simvastatin in lowering LDL-cholesterol was directly studied in several clinical trials; both drugs showed similar efficacy in managing symptoms related to hyperlipidemia as well as similar safety profiles.
A 2003 meta-analysis indicated that rosuvastatin is effective at reducing LDL-cholesterol levels from the first week of treatment, that its side effect profile is comparable to many other statins, and it is well-tolerated even in elderly populations. This study also reported that rosuvastatin has become one of the most widely-prescribed statin drugs globally. It's worth mentioning that doses showing optimal efficacy vary depending on individual lipid profiles but generally lie within 5 - 40mg/day range.
In contrast, a review published in 2011 stated simvastatin seems more effective than placebo for preventing cardiovascular events pertaining to elevated cholesterol levels. However, it typically considered an earlier line treatment option due to its longer presence on the market compared to newer generation statins like Crestor. Simvastatin dosing usually falls between 10 – 40 mg daily but can go up to 80 mg although this higher dose carries increased risk for muscle-related side effects such as rhabdomyolysis.
It should be noted though while both medications are part of same drug class there are differences including potency where Rosuvstatin has been shown generally being more potent than Simvistation at equal doses which might make it a better choice for individuals with particularly high cholesterol levels or those who don't respond sufficiently enough lower intensity treatments.
Related trials for rosuvastatin and simvastatin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Rosuvastatin typically prescribed?
Oral dosages of Rosuvastatin range from 5-40 mg/day, but studies have indicated that a daily dose of 10–20mg is effective for most people in treating high cholesterol and reducing the risks associated with heart disease. The starting dose may be lower for certain populations including those over age 70 or patients with kidney problems. On the other hand, Simvastatin dosages typically range between 10-40 mg/day taken in the evening, although some individuals with very high LDL levels may require up to an 80mg daily dose. As always, any dosage adjustments should be made under physician supervision and based on individual response and tolerance to treatment.
At what dose is Simvastatin typically prescribed?
Simvastatin treatment is typically initiated at a dosage of 10-20 mg/day, taken in the evening. The dose can be increased to a maximum of 40 mg/day if cholesterol levels have not adequately reduced after several weeks. Some patients with high cardiovascular risk may start directly on 40mg per day. It's important to note that Simvastatin doses above 40 mg/day are not recommended due to the increased risk of muscle damage (myopathy). As always, dosing adjustments should be done under medical supervision based on individual response and tolerability.
What are the most common side effects for Rosuvastatin?
Common side effects of Rosuvastatin and Simvastatin include:
- Headache
- Nausea
- Abdominal pain or discomfort (dyspepsia)
- Constipation, diarrhea
- Muscle aches or spasms, weakness (myalgia)
- Dizziness, insomnia
- Flushing of the skin especially on face and neck
- Mild rash or itching Increased levels of sugar in your blood
Please remember that while these are the common side effects, everyone reacts differently to medications. If you notice any unusual symptoms after starting one of these drugs, it's important to contact your healthcare provider as soon as possible for assessment.
Are there any potential serious side effects for Rosuvastatin?
While both Rosuvastatin and Simvastatin are generally well-tolerated, they can cause serious side effects in rare cases. These may include:
- Signs of an allergic reaction, such as hives; difficulty breathing; swelling of your face, lips, tongue or throat.
- Liver problems: upper stomach pain, tiredness, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes).
- Kidney problems: little or no urination; painful or difficult urination; swelling in your feet or ankles; feeling tired.
- Unexplained muscle pain or weakness especially if you also have fever, unusual fatigue and dark colored urine - a condition known as rhabdomyolysis which could lead to kidney failure
- Memory issues: forgetfulness/confusion
If you experience any of these symptoms while taking either Rosuvastatin or Simvastatin it is important that you seek medical attention immediately.
What are the most common side effects for Simvastatin?
Simvastatin, like Rosuvastatin, is a statin used to control high cholesterol. However, the side effects can differ slightly. Some users of Simvastatin may experience:
- Headache or dizziness
- Nausea, indigestion or abdominal pain
- Constipation or diarrhea
- Sleep disturbances such as insomnia
- Rash on skin
- Muscle or joint pain.
More rarely but importantly, Simvastatin has been associated with muscle breakdown (rhabdomyolysis) and liver problems which are serious conditions that require immediate medical attention. As always, it's important to discuss these potential side effects with your healthcare provider when choosing between medications.
Are there any potential serious side effects for Simvastatin?
While Simvastatin is generally safe and effective for lowering cholesterol, it's important to be aware of potential side effects. These can include:
- Signs of an allergic reaction including hives, itching, swollen glands or a swelling in your face or throat. If you experience difficulty breathing alongside these symptoms seek medical help immediately.
- Severe muscle pain which could indicate the onset of a condition called rhabdomyolysis that can lead to kidney failure.
- Jaundice (yellowing skin and eyes) which could hint at liver problems.
- Unusual fatigue or weakness as this may be a sign of anaemia.
- Blurred vision: check with your healthcare provider as soon as possible if you notice changes in your sight while taking Simvastatin. If any such severe reactions occur after starting on Simvastatin, discontinue use immediately and consult with your doctor promptly.
Contraindications for Rosuvastatin and Simvastatin?
Both rosuvastatin and simvastatin, like most other cholesterol-lowering medications, may cause certain side effects in some people. If you notice muscle pain or weakness, unexplained fatigue, or dark colored urine while on either drug, it is important to seek immediate medical attention as these could be signs of a rare but serious side effect called rhabdomyolysis.
Neither rosuvastatin nor simvastatin should be taken if you are taking drugs that inhibit CYP3A4 (a liver enzyme), such as certain antibiotics (like erythromycin) and antifungal drugs (like itraconazole). These drugs can increase the amount of statin in your blood and raise your risk for side effects. Always inform your physician about any medication you are currently taking; those that affect the action of liver enzymes will require careful management to prevent dangerous interactions with rosuvastatin and simvastatin.
How much do Rosuvastatin and Simvastatin cost?
For the brand name versions of these drugs:
- The price for 30 tablets of Crestor (Rosuvastatin, 10 mg) averages around $200, which works out to approximately $6.66 per day.
- The price for a similar quantity and strength of Zocor (Simvastatin, 20 mg) is about $220, working out to roughly $7.33 per day.
Thus if you are on equivalent dosages, then brand-name Crestor is generally less expensive on a per-day treatment basis than Zocor. However, cost should not be the only consideration in determining which statin is right for you; efficacy and side-effect profile are also important factors.
For generic versions:
- Generic rosuvastatin costs between $0.28 and $2.50/day depending on dose and where it's purchased.
- Simvastatin ranges from about $.07 to $.80/day based on dose and location.
These prices can vary considerably by region or pharmacy so always check with your local providers before making any decisions solely based on cost alone.
Popularity of Rosuvastatin and Simvastatin
Rosuvastatin, available in generic form and under the brand name Crestor, was prescribed to about 21 million people in the US in 2020. It accounted for around 20% of statin prescriptions in the country. Rosuvastatin is one of the newest members of the statin class of drugs, which are used primarily as a lipid-lowering agent in those who require intensive therapy.
Simvastatin, including its brand-name version Zocor, was prescribed to approximately 18 million people in America during that same year. In terms of overall statin use within the US population, simvastatin represents a share just shy of 18%. This statin has been on the market longer than rosuvastatin and its prescription rate has remained relatively stable over time.
Although both medications serve similar purposes—lowering cholesterol levels—there are differences between them regarding dosages and potential side effects. These factors can influence doctors' decisions when prescribing either medication.
Conclusion
Both rosuvastatin and simvastatin are widely used in the management of high cholesterol levels, with extensive clinical trials and studies demonstrating their efficacy compared to placebo treatments. They work by inhibiting an enzyme involved in the production of cholesterol in the liver (HMG-CoA reductase), hence they belong to a class of drugs known as statins.
Rosuvastatin is often prescribed when aggressive lowering of LDL (“bad”) cholesterol is needed because it's more potent than simvastatin at equivalent doses. Simvastatin, on the other hand, has been around longer and there’s more long-term data available about its safety.
Both medications are available as generic prescriptions which can provide significant cost savings for patients paying out-of-pocket. The initiation phase may require some adjustments based on patient response and tolerability.
The side effect profiles for both drugs are similar - most commonly reported side effects include muscle pain or weakness, headache, nausea among others but rosuvastatin can be less likely to cause certain side effects like muscle pain known associated with statin use. Patients should monitor their health closely upon starting these treatments; any severe reaction or unexpected worsening should prompt urgent medical consultation.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- McKenney, J. M., Jones, P. H., Adamczyk, M. A., Cain, V. A., Bryzinski, B. S., Blasetto, J. W., & for the STELLAR Study Group. (2003, January). Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Current Medical Research and Opinion. Informa UK Limited.http://doi.org/10.1185/030079903125002405
- Davidson, M. H., Stein, E. A., Dujovne, C. A., Hunninghake, D. B., Weiss, S. R., Knopp, R. H., … Tobert, J. A. (1997, January). The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day. The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/s0002-9149(96)00742-4
- Rosenson, R. S. (2003, November). Rosuvastatin: a new inhibitor of HMG-CoA reductase for the treatment of dyslipidemia. Expert Review of Cardiovascular Therapy. Informa UK Limited.http://doi.org/10.1586/14779072.1.4.495
- Lopez, L. M. (2005, July). Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor. Journal of the American Pharmacists Association. Elsevier BV.http://doi.org/10.1331/1544345054475522
- CHENG, J. (2004, September). Rosuvastatin in the management of hyperlipidemia. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/j.clinthera.2004.09.005
- Cournot, M., Cambou, J.-P., Quentzel, S., & Danchin, N. (2006, July). Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys. International Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/j.ijcard.2005.06.039
- Huynh, T., Cordato, D., Yang, F., Choy, T., Johnstone, K., Bagnall, F., … Dunn, R. (2002, September). HMG CoA reductase‐inhibitor‐related myopathy and the influence of drug interactions. Internal Medicine Journal. Wiley.http://doi.org/10.1046/j.1445-5994.2002.00264.x
- Al Shohaib, S. (2000). Simvastatin-Induced Rhabdomyolysis in a Patient with Chronic Renal Failure. American Journal of Nephrology. S. Karger AG.http://doi.org/10.1159/000013589
- Bottorff, M. B. (2006, April). Statin Safety and Drug Interactions: Clinical Implications. The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/j.amjcard.2005.12.007
- Mazza, F., Stefanutti, C., Di Giacomo, S., Vivenzio, A., Fraone, N., Mazzarella, B., & Bucci, A. (2008). Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles. American Journal of Cardiovascular Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00129784-200808040-00006